Gatlin pharmacy tech students offered internships at CVS
DALLAS As part of a new agreement with Gatlin Education Services, CVS will offer its externship program to students in several CVS districts who are taking Gatlin’s pharmacy technician online career training program.
Gatlin’s online learning program teaches the necessary skills to gain employment as a pharmacy technician in a hospital or retail setting. The course aims to provide high school graduates and individuals seeking new careers the skills and knowledge that will enable them to qualify for entry-level positions in pharmacies as well as prepare for the mandated national certification.
Gatlin and CVS initially expect to enroll about a dozen students in the internship program every month, with that number doubling in a year’s time.
ActivePHR wins CDHC award
NEW YORK ActivePHR, ActiveHealth Management’s personal health record has been named a winner of the 2008 Consumer Driven Health Care Solutions Award for Most Effective Solution Provider, as awarded by CDHC Solutions magazine.
The ActivePHR program provides an electronic home for a person’s health information. ActivePHR generates actionable alerts when opportunities to improve care are identified. Other innovative features within ActivePHR include integration with ActiveHealth’s health risk assessment and disease management program, the ability to grant access to doctors/caregivers, health trackers, calendar, and translation to Spanish.
“Consumers need and want to take an increased role in their healthcare,” said Peter Neupert, corporate vice president of Microsoft Health Solutions Group. “A personal health record like ActivePHR empowers consumers. When consumers have the ability to present a complete picture of their health and information on specific issues to all of their doctors and caregivers, the result is better care.”
Danish company finds potential weight-loss drug
NEW YORK Good results from a study of a new drug from Denmark-based NeuroSearch caused the company’s stock to increase the most in more than a month, according to Bloomberg.
Studies of the experimental drug tesofensine showed that it improved fat metabolism and lowered weight. The results caused NeuroSearch’s stock to rise by about $2.20 to $50.77, a 4.5 percent increase.
The drug company said it hoped to find a partner to fund the testing required to gain regulatory approval for the drug, which could generate $1.1 billion in sales if approved.
One dollar equaled 5 kroner, as of mid-day Tuesday.